Medication errors in chronic kidney disease: one piece in the patient safety puzzle

Area of Science:

• Nephrology
• Patient Safety
• Pharmacovigilance

Background:

• Patients with chronic kidney disease (CKD) face elevated risks of medical errors.
• Adverse drug events (ADEs) represent a critical threat to the safety of hospitalized individuals with CKD.

Discussion:

• The study by Hug and colleagues underscores the substantial impact of ADEs on CKD patient safety.
• Findings highlight the prevalence and consequences of medical errors in this vulnerable population.

Key Insights:

• ADEs are a major contributor to patient harm in hospitalized CKD patients.
• There is a clear need for targeted interventions to mitigate ADEs in CKD care.

Outlook:

• Development and implementation of novel strategies are crucial for reducing medical errors and improving safety for CKD patients.
• Future research should focus on effective preventative measures and best practices in medication management for individuals with CKD.